Bloom Could Come Off Intuitive Surgical's (ISRG) Rose as Lawsuits Fly - Citron
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Intuitive Surgical (ISRG) Sees Mid-Day Bounce
December 21, 2012 11:05 AM ESTAfter getting pummeled the past few session on the Citron Research short report, Intuitive Surgical, Inc. (NASDAQ: ISRG) is bouncing mid-day. Shares are up 1.8%. They are down 11% since the report came out.... More
Intuitive Surgical (ISRG) Still Mum on Citron Report, But Analysts Weigh-In
December 20, 2012 5:02 PM ESTIn a follow-up to an earlier article...
Down 11 percent over two days, Intuitive Surgical, Inc. (NASDAQ: ISRG) would not comment to StreetInsider.com on the attack from short selling website Citron Research. However, the company is pointing us to two analyst reports, one from Raymond James and the other from Lazard Capital Markets, discussing the matter.
First, Raymond James analyst Lawrence Keusch said that after reviewing the... More
Intuitive Surgical (ISRG) and Analysts Quiet as a Mouse Despite Short Attack
December 20, 2012 11:54 AM ESTIntuitive Surgical, Inc. (NASDAQ: ISRG) has lost nearly $50 per share, or 8%, since short selling website Citron Research targeted the maker of... More
Intuitive Surgical (ISRG) Sees Mid-Day Pressure
December 19, 2012 12:26 PM ESTIntuitive Surgical, Inc. (NASDAQ: ISRG) seeing weakness on negative Citron write-up... More
